Isolated megalencephaly

Isolated megalencephaly (also known as benign familial megalencephaly, idiopathic megalencephaly, or primary megalencephaly) is a rare neurological condition characterized by an abnormally enlarged brain (megalencephaly) that is not associated with other structural brain malformations, metabolic disorders, or syndromic conditions. The brain weight or volume exceeds the mean for age and sex by more than two standard deviations. This condition primarily affects the central nervous system and is typically identified in infancy or early childhood when head circumference measurements are noted to be above the 98th percentile (macrocephaly). In many cases, isolated megalencephaly follows a benign course, particularly when it occurs in a familial context where one or both parents also have large heads. Affected individuals may have normal cognitive development and neurological function. However, some patients may experience developmental delay, mild intellectual disability, seizures, or mild motor difficulties. The degree of neurological involvement varies considerably among affected individuals, ranging from completely asymptomatic to mild neurodevelopmental concerns. Diagnosis is typically made through clinical assessment of head circumference, family history evaluation, and neuroimaging (MRI) to exclude other causes of macrocephaly such as hydrocephalus, storage disorders, or hemimegalencephaly. There is no specific treatment for isolated megalencephaly itself. Management is supportive and may include developmental monitoring, early intervention services for those with developmental delays, and seizure management with antiepileptic medications if epilepsy is present. Regular follow-up with a pediatric neurologist is recommended to monitor neurodevelopmental progress.

Common questions about Isolated megalencephaly